In today’s recent session, 0.91 million shares of the Teladoc Health Inc. (NYSE:TDOC) have been traded, and its beta is 0.86. Most recently the company’s share price was $33.47, and it changed around $1.96 or 6.22% from the last close, which brings the market valuation of the company to $4.82B. TDOC at last check was trading at a discount to its 52-week high of $174.32, offering almost -420.82% off that amount. The share price’s 52-week low was $27.38, which indicates that the recent value has risen by an impressive 18.2% since then. We note from Teladoc Health Inc.’s average daily trading volume that its 10-day average is 5.59 million shares, with the 3-month average coming to 7.77 million.
Teladoc Health Inc. stock received a consensus recommendation rating of an Overweight, based on a mean score of 2.60. If we narrow it down even further, the data shows that 0 out of 28 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 20 recommended TDOC as a Hold, whereas 8 deemed it a Buy, and 0 rated it as Underweight. Teladoc Health Inc. is expected to report earnings per share of -$0.64 for the current quarter.
Teladoc Health Inc. (NYSE:TDOC) trade information
Instantly TDOC has been showing a green trend so far today with a performance of 6.22% on intraday trading today. The performance over the last five days has remained in the green territory. The rise to weekly highs of 32.75 on Tuesday, 06/21/22 decreased the stock’s daily price by -2.2%. The company’s shares are currently down -65.68% year-to-date, but still up 10.06% over the last five days. On the other hand, Teladoc Health Inc. (NYSE:TDOC) is -4.25% up in the 30-day period. We can see from the shorts that 36.84 million shares have been sold at a short interest cover period of 3.72 day(s).
The consensus price target as assigned by Wall Street analysts is $44.00, which translates to bulls needing to increase their stock price by 23.93% from its current value. Analyst projections state that TDOC is forecast to be at a low of $30.00 and a high of $65.00. In order for the stock price to hit the forecast high, the stock would need to plunge -94.2% from its current level, while the stock would need to crash 10.37% from its current level to reach the projected low.
Teladoc Health Inc. (TDOC) estimates and forecasts
Teladoc Health Inc. share prices are performing particularly well not compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -67.77 percent over the past six months and at a -3,146.62% annual growth rate that is well below the industry average of -0.20%. Moreover, analysts have decided to roll up on their fiscal year 2022 revenue estimates. The rating firms predict that it will gain 25.60% in revenue this quarter, and will report a decrease of -3.80% in the next quarter. The year-over-year growth rate is expected to be 19.60%, up from the previous year.
Consensus estimates provided by 22 financial analysts predict the company will bring in an average of $587.34 million in revenue for the current quarter. 21 analysts expect Teladoc Health Inc. to make $618.65 million in revenue for the quarter ending Sep 2022.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -9.30%.
Teladoc Health Inc.’s next quarterly earnings report is expected to be released around July 25 and July 29.
Teladoc Health Inc. (NYSE:TDOC)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 1.36% of Teladoc Health Inc. shares, and 84.11% of them are in the hands of institutional investors. The stock currently has a share float of 85.26%. Teladoc Health Inc. stock is held by 1,021 institutions, with ARK Investment Management, LLC being the largest institutional investor. By Mar 30, 2022, it held 12.08% of the shares, which is about 19.47 million shares worth $1.4 billion.
Vanguard Group, Inc. (The), with 8.21% or 13.24 million shares worth $954.87 million as of Mar 30, 2022, holds the second largest percentage of outstanding shares.
ARK ETF Tr-ARK Innovation ETF and Vanguard Total Stock Market Index Fund were the top two Mutual Funds as of May 30, 2022. The former held 11.96 million shares worth $407.58 million, making up 7.42% of all outstanding shares. On the other hand, Vanguard Total Stock Market Index Fund held roughly 4.18 million shares worth around $301.55 million, which represents about 2.59% of the total shares outstanding.